Evidence map›Paper›PMID 33830220›Full record

ArticleNeuro-oncology2021

Prognostic factors in leptomeningeal metastases.

Emilie Le Rhun, Patrick Devos, Johannes Weller, Katharina Seystahl, Francesca Mo, Anette Compter, Anna S Berghoff, Joost L M Jongen, Fabian Wolpert, Roberta Rudà and 5 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Emilie Le RhunUniversity of Lille, Inserm, U-1192, Lille, France.
Patrick DevosClinical Neuroscience Center and Comprehensive Cancer Center, University Hospital and University of Zurich, Zurich, Switzerland.
Johannes WellerDivision of Clinical Neuro-Oncology, Department of Neurology, University Hospital Bonn, Venusberg Campus, Bonn, Germany.
Katharina SeystahlDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Francesca MoDepartment of Neuro-Oncology, City of Health and Science University of Turin, Turin, Italy.
Anette CompterDepartment of Neuro-Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Anna S BerghoffDepartment of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Joost L M JongenBrain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Fabian WolpertDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Roberta RudàDepartment of Neuro-Oncology, City of Health and Science University of Turin, Turin, Italy.
Dieta BrandsmaDepartment of Neuro-Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands.ORCID 0000-0001-7998-9904
Martin van den BentBrain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Matthias PreusserDepartment of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Ulrich HerrlingerDivision of Clinical Neuro-Oncology, Department of Neurology, University Hospital Bonn, Venusberg Campus, Bonn, Germany.
Michael WellerDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.ORCID 0000-0002-1748-174X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Meningeal CarcinomatosisMeningeal NeoplasmsHumansPrognosis

Identifiers

PMID33830220
PMCPMC8248845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.